Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Amesite Inc./ S-8

SEC Filing · S-8

Amesite Inc.

AMSTNASDAQEQUITYCurrent

SEC Filing

Filed Jul 30, 2026Accepted Jul 30, 2026, 5:30 PM EDTCIK 1807166Accession 0001213900-26-083438
View company →Permanent SEC source ↗
Share

Company context

Amesite is a technology company focused on building and commercializing AI-powered solutions for the healthcare sector, with particular emphasis on the post-acute care market. In fiscal 2025, we completed our pivot from an education-centric model to one firmly anchored in the demands and opportunities of healthcare—a shift driven by the scale, complexity, and attractive growth potential of this sector.

Current securities

AMSTNASDAQ · EQUITY · Current

Recent company filings

  1. 10-K filingSep 23, 2026
  2. Shareholder Director Nominations · Other EventsSep 17, 2026
  3. Regulation FD DisclosureSep 11, 2026
  4. Entry into a Material Definitive AgreementJul 20, 2026
  5. 424B5 filingJul 17, 2026

As-filed source

Primary evidence
As filedOpen full document ↗